Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision indicator was updated from v3.5.3 to v3.5.4, reflecting a new UI/version update. This change does not affect the trial details or other user-facing information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a site release change rather than any alteration to the underlying study record details.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check80 days agoChange DetectedThe site revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check109 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 is displayed on the page, with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.